» Articles » PMID: 25446987

MALAT1 Promotes Colorectal Cancer Cell Proliferation/migration/invasion Via PRKA Kinase Anchor Protein 9

Overview
Specialties Biochemistry
Biophysics
Date 2014 Dec 3
PMID 25446987
Citations 116
Authors
Affiliations
Soon will be listed here.
Abstract

Our previous studies have shown that the 3' end of metastasis associated lung adenocarcinoma transcript 1 (MALAT1) is involved in colorectal cancer (CRC) cell proliferation and migration/invasion in vitro. The role and mechanism of MALAT1 in CRC metastasis in vivo, however, remain largely unknown. In the present study, we found that MALAT1 was up-regulated in human primary CRC tissues with lymph node metastasis. Overexpression of MALAT1 via RNA activation promoted CRC cell proliferation, invasion and migration in vitro, and stimulated tumor growth and metastasis in mice in vivo. Conversely, knockdown of MALAT1 inhibited CRC tumor growth and metastasis. MALAT1 regulated at least 243 genes in CRC cells in a genome-wide expression profiling. Among these genes, PRKA kinase anchor protein 9 (AKAP-9) was significantly up-regulated at both mRNA and protein levels. AKAP-9 was highly expressed in CRC cells with metastatic potential and human primary CRC tissues with lymph node metastasis, but not in normal cells or tissues. Importantly, knockdown of AKAP-9 blocked MALAT1-mediated CRC cell proliferation, migration and invasion. These data indicate that MALAT1 may promote CRC tumor development via its target protein AKAP-9.

Citing Articles

LncRNA FAM30A Suppresses Proliferation and Metastasis of Colorectal Carcinoma by Blocking the JAK-STAT Signalling.

Liu J, Han S, Cui Y, Zhao Q, Wang Y, Li T J Cell Mol Med. 2025; 29(4):e70421.

PMID: 39972942 PMC: 11839745. DOI: 10.1111/jcmm.70421.


Diagnostics and Therapy for Malignant Tumors.

Tsai C, Wang C, Chang H, Chang P, Chang C, Chu T Biomedicines. 2025; 12(12.

PMID: 39767566 PMC: 11726849. DOI: 10.3390/biomedicines12122659.


LncRNA MALAT1 as diagnostic and prognostic biomarker in colorectal cancers: A systematic review and meta-analysis.

Masrour M, Khanmohammadi S, Habibzadeh A, Fallahtafti P PLoS One. 2024; 19(10):e0308009.

PMID: 39471147 PMC: 11521308. DOI: 10.1371/journal.pone.0308009.


Predictors of early colorectal cancer metastasis to lymph nodes: providing rationale for therapy decisions.

Song X, Li J, Zhu J, Kong Y, Zhou Y, Wang Z Front Oncol. 2024; 14:1371599.

PMID: 39035744 PMC: 11257837. DOI: 10.3389/fonc.2024.1371599.


AKAP8 promotes ovarian cancer progression and antagonizes PARP inhibitor sensitivity through regulating hnRNPUL1 transcription.

Mobet Y, Wang H, Wei Q, Liu X, Yang D, Zhao H iScience. 2024; 27(5):109744.

PMID: 38711442 PMC: 11070336. DOI: 10.1016/j.isci.2024.109744.


References
1.
Caria P, Vanni R . Cytogenetic and molecular events in adenoma and well-differentiated thyroid follicular-cell neoplasia. Cancer Genet Cytogenet. 2010; 203(1):21-9. DOI: 10.1016/j.cancergencyto.2010.08.025. View

2.
Truong T, Sauter W, McKay J, Hosgood 3rd H, Gallagher C, Amos C . International Lung Cancer Consortium: coordinated association study of 10 potential lung cancer susceptibility variants. Carcinogenesis. 2010; 31(4):625-33. PMC: 2847090. DOI: 10.1093/carcin/bgq001. View

3.
Schmitt A, Chang H . Gene regulation: Long RNAs wire up cancer growth. Nature. 2013; 500(7464):536-7. PMC: 5332550. DOI: 10.1038/nature12548. View

4.
Lai M, Yang Z, Zhou L, Zhu Q, Xie H, Zhang F . Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol. 2011; 29(3):1810-6. DOI: 10.1007/s12032-011-0004-z. View

5.
Huang T, Alvarez A, Hu B, Cheng S . Noncoding RNAs in cancer and cancer stem cells. Chin J Cancer. 2013; 32(11):582-93. PMC: 3845549. DOI: 10.5732/cjc.013.10170. View